PHILADELPHIA, Feb. 16 /PRNewswire/ -- InnaPhase Corporation, a world- leading provider of enterprise Laboratory Information Management System (LIMS) solutions, today announced the addition of Michael Tyszkiewicz, formerly of Applied Biosystems, as director of product development.
Mr. Tyszkiewicz's primary focus at InnaPhase will be to guide product development strategies in preparation for a new product release to be previewed at the 2004 Pittsburgh Conference. With over 30 years experience in laboratories, he has focused for 20 years on LIMS solutions, including implementation, system management, sales and product development. Previously, Mr. Tyszkiewicz managed professional services at Applied Biosystems, developing methodology and project management for the delivery of successfully validated LIMS solutions in the pharmaceutical industry. He studied chemistry at Rutgers University and information technology at Louisiana State University.
"I am just delighted to have Mike join InnaPhase and our strong product development team," said Jo Webber, Ph.D., President and CEO of InnaPhase Corporation. "His thorough knowledge of business processes and information systems within the petrochemical and manufacturing industries, in addition to pharmaceutical and biotech, is a real asset to the long-term goals of the company. We are confident Mike's leadership and expertise will yield a vertical LIMS solution that will open new markets for InnaPhase."
"The opportunity to join InnaPhase was one I just couldn't pass up," said Mr. Tyszkiewicz. "The company has a superb reputation within the LIMS industry. And I wanted to be a part of the organization's strategic plan to serve new industries with purpose-built LIMS that are as strong as InnaPhase's offerings to the pharmaceutical industry."
InnaPhase Corporation provides 18 of the world's top 20 pharmaceutical organizations with its products and services. The Pharma LIMS(TM) Suite is a series of purpose-built LIMS applications for the pharmaceutical industry and is designed to operate in a 21 CFR Part 11 compliant environment. The Pharma LIMS Suite includes: Newton(TM) LIMS for batch release, quality control, formulation, stability and analytical development; Watson(TM) LIMS for pre-clinical and clinical bioanalysis; and Galileo(TM) LIMS for In Vitro testing. InnaPhase also markets LabManager iLIMS as well as PeakPro and Pinnacle Chromatography Data Systems. InnaPhase has locations in the United States, the United Kingdom, Germany, The Netherlands and distribution centers in India and Japan. For more information, see InnaPhase on the World Wide Web at http://www.innaphase.com/.
CONTACT: Kathleen Beaulieu, InnaPhase Corporation, +1-508-528-9004,email@example.com